Gnosis has more than 25 years of experience in the production of microbial-derived biopharmaceuticals for both oral and injectable use. With our proprietary technology and sophisticated know-how, we are today a leading manufacturer of active and functional ingredients for the nutrition, cosmetic, personal care, industrial biotech and pharmaceutical industries and we are proud to have supplied a wide range of high quality products to our customers over the years.
Look at the evolution of Gnosis since its foundation.
Gnosis is founded by a group of technicians and scientists to provide a reliable source of scientific and technological services.
The large scale manufacturing of Active Pharmaceutical Ingredients starts by using outsourcing partners.
Gnosis decides to expand the R&D lab through the construction of the R&D center in Desio (Milan, Italy).
Gnosis acquires the Sant’Antonino manufacturing site in Switzerland from Abbott (formerly known as Abbott Knoll Bioresearch).
New manufacturing areas were built and qualified to introduce advanced technologies and increasing the range of products manufactured in Sant' Antonino.
Gnosis advances its research and commercial capability with the acquisition of Pisticci Site from Pfizer, in Southern Italy.
North America Branch Office is established in USA to provide client-oriented services and to develop Gnosis' worldwide relationship.
In order to strengthen its business position in Asia-Pacific area, Gnosis opens its Branch Office in Shanghai, China's leading center.
Gnosis manufacturing sites located in Switzerland and Italy are both successfully inspected by US FDA.
US FDA Approval
Lesaffre majority participation in Gnosis
Gnosis and Lesaffre start a new partnership aimed to increase industrial synergies and development of common interest areas.
Gnosis development proceeds with the diversification of the Pisticci manufacturing site with two dedicated areas for pharmaceuticals and nutraceuticals production.